MERIDIA (sibutramine hydrochloride monohydrate) is indicated for the management of obesity, including weight loss and
maintenance of weight loss, and should be used in conjunction with a reduced
calorie diet. MERIDIA (sibutramine hydrochloride monohydrate) is recommended for obese patients with an initial body
mass index ≥ 30 kg/m², or ≥ 27 kg/m² in the presence of other
risk factors (e.g., diabetes, dyslipidemia, controlled hypertension).
Below is a chart of Body Mass Index (BMI) based on various heights and weights.
BMI is calculated by ta...
Read the complete drug monograph for Meridia »